Teva MDL Loss Shows DPAs Can Return To Haunt Civil Suits
By Lindsey Collins, T.J. Benedict and Ann O’Brien · September 4, 2026, 2:25 PM EDT
In ongoing multidistrict antitrust litigation alleging price-fixing by numerous generic-drug manufacturers, the U.S. District Court for the Eastern District of Pennsylvania issued a significant opinion on July 27 with direct implications...
To view the full article, register now.